Radioiodine Ablation for Differentiated Thyroid Cancer—None, One Dose or Two?
Received 28 August 2009; received in revised form 12 October 2009; accepted 10 November 2009.
Abstract
Patients with good prognosis differentiated thyroid cancer are at risk from over-treatment with radioiodine thyroid remnant ablation. Some with unfavourable localised disease might benefit from an elective second dose.
ABSTRACT